PentixaPharm is Drug Discovery in Germany that focus on protective environment business. Founded in 2019. They cover business area such as developer, theranostic radiopharmaceutical pair, fast progressing disease, proliferation, hematologic and solid tumor, their protective environment, therapeutic counterpart, healthcare professional, new treatment option, individualized medicine, term, endoradiotherapy, patient, benefit, exist therapy, a reduce side effect profile.
2019
( 5 years old in 2024 )
Protective Environment
-
Bismarckstrasse 13
Bavaria
97080 Würzburg
Germany
Private
developertheranostic radiopharmaceutical pairfast progressing diseaseproliferationhematologic and solid tumortheir protective environmenttherapeutic counterparthealthcare professionalnew treatment optionindividualized medicinetermendoradiotherapypatientbenefitexist therapya reduce side effect profile
* We use standard office opening hours in near PentixaPharm's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PentixaPharm is Drug Discovery business from Germany that founded in 2019 (5 years old in 2024), PentixaPharm business is focusing on Protective Environment.
PentixaPharm headquarter office and corporate office address is located in Bismarckstrasse 13 Bavaria 97080 Würzburg Germany.
PentixaPharm was founded in Germany.
In 2024, PentixaPharm is currently focus on protective environment sector.
Above is snippet of Google Trends for "protective environment" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PentixaPharm, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
